“发现热休克蛋白90的吲哚唑抑制剂作为抗癌剂”的勘误[欧洲]。医学化学。(2024) 116620)

IF 6 2区医学 Q1 CHEMISTRY, MEDICINAL

European Journal of Medicinal Chemistry Pub Date : 2024-12-24 DOI:10.1016/j.ejmech.2024.117194

Minh Thanh La, Van-Hai Hoang, Raghaba Sahu, Cong-Truong Nguyen, Gibeom Nam, Hyun-Ju Park, Minsu Park, Yoon-Jae Kim, Ji Young Kim, Jihyae Ann, Jae Hong Seo, Jeewoo Lee

{"title":"“发现热休克蛋白90的吲哚唑抑制剂作为抗癌剂”的勘误[欧洲]。医学化学。(2024) 116620)","authors":"Minh Thanh La, Van-Hai Hoang, Raghaba Sahu, Cong-Truong Nguyen, Gibeom Nam, Hyun-Ju Park, Minsu Park, Yoon-Jae Kim, Ji Young Kim, Jihyae Ann, Jae Hong Seo, Jeewoo Lee","doi":"10.1016/j.ejmech.2024.117194","DOIUrl":null,"url":null,"abstract":"The authors regret the omission of funding information for grant number 2023R1A2C3004010 in the Acknowledgments section of the original publication. The authors would like to amend the Acknowledgments as follows:","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"58 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents” [Eur. J. Med. Chem. (2024) 116620]\",\"authors\":\"Minh Thanh La, Van-Hai Hoang, Raghaba Sahu, Cong-Truong Nguyen, Gibeom Nam, Hyun-Ju Park, Minsu Park, Yoon-Jae Kim, Ji Young Kim, Jihyae Ann, Jae Hong Seo, Jeewoo Lee\",\"doi\":\"10.1016/j.ejmech.2024.117194\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The authors regret the omission of funding information for grant number 2023R1A2C3004010 in the Acknowledgments section of the original publication. The authors would like to amend the Acknowledgments as follows:\",\"PeriodicalId\":314,\"journal\":{\"name\":\"European Journal of Medicinal Chemistry\",\"volume\":\"58 1\",\"pages\":\"\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2024-12-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejmech.2024.117194\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejmech.2024.117194","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}

引用次数: 0

摘要

作者很遗憾在原始出版物的致谢部分遗漏了资助号为2023R1A2C3004010的资助信息。作者希望对致谢作如下修改：

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Corrigendum to “Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents” [Eur. J. Med. Chem. (2024) 116620]

The authors regret the omission of funding information for grant number 2023R1A2C3004010 in the Acknowledgments section of the original publication. The authors would like to amend the Acknowledgments as follows:

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European Journal of Medicinal Chemistry 化学-医药化学

CiteScore

11.70

自引率

9.00%

发文量

863

审稿时长

29 days

期刊介绍： The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.